Published November 2008 | Version v1
Journal article

Methodology study on isotopic tracing HSA-IFN-α2b in vivo

  • 1. The Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Inst. of Nuclear Medicine, Wuxi (China)
  • 2. Wolwo Biological Technology Co., Ltd., Shanghai (China)

Description

125I-HSA-IFN-α2b was prepared with the method of CH-T. The labelling yields was 82.72%, radiochemical purity was more than 95% and the radioactivity was 0.26 TBq/g. The activity of antivirus of 125I-HSA-IFN-α2b was compared with that of HSA-IFN-α2b by WISH/VSV system in vitro. The results showed that bioactivity of HSA-IFN-α2b had no change before and after being labelled.The serum recovery 102.0% and organ recovery 104.0%(heart), 100.4%(lung), 100.9%(liver), 104.1%(spleen), 101.4%(kidney), 103.0%(small intestine)of 125I-HSA-IFN-α2b met the requirements. The results of the interference experiments showed that there was no interference on the determination. There- fore, 125I-HSA-IFN-α2b can be used in studying biodistribution and excretion of HSA-IFN-α2b. (authors)

Additional details

Publishing Information

Journal Title
Journal of Isotopes
Journal Volume
21
Journal Issue
4
Journal Page Range
p. 220-225
ISSN
1000-7512

Optional Information

Notes
14 figs., 2 tabs., 6 refs.